Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles

Theranostics

Volumn 2, Issue 1, 2012, Pages 86-102

  Huang, Jing ^a   Zhong, Xiaodong ^b   Wang, Liya ^a   Yang, Lily ^a   Mao, Hui ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MR Research and Development   (United States)

Author keywords

Engineering; Functionalizing; Magnetic nanoparticles; Magnetic resonance imaging

Indexed keywords

MAGNETIC NANOPARTICLE; NOSCAPINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VITRONECTIN RECEPTOR;

CHEMICAL COMPOSITION; CONTRAST ENHANCEMENT; FLUORESCENCE IMAGING; HUMAN; HYDROPHOBICITY; ISOTOPE LABELING; MOLECULARLY TARGETED THERAPY; NANOENGINEERING; NANOPROBE; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; REVIEW; SURFACE PROPERTY;

EID: 84860917662     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4006     Document Type: Review

References (80)

1. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26: 3995-4021.
2. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008; 108: 2064-110.
3. Gao J, Gu H, Xu B. Multifunctional Magnetic Nanoparticles: Design, Synthesis, and Biomedical Applications. Acc Chem Res. 2009; 42: 1097-107.
4. Xie J, Huang J, Li X, Sun S, Chen X. Iron Oxide Nanoparticle Platform for Biomedical Applications. Curr Med Chem. 2009; 16: 1278-94.
5. Kim BYS, Rutka JT, Chan WCW. Current Concepts: Nanomedicine. New Engl J Med. 2010; 363: 2434-43.
6. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Delivery Rev. 2010; 62: 1064-79.
7. Xie J, Liu G, Eden HS, Ai H, Chen X. Surface-Engineered Magnetic Nanoparticle Platforms for Cancer Imaging and Therapy. Acc Chem Res. 2011; 44: 883-92.
8. Lee JH, Huh YM, Jun YW, Seo Jw, Jang Jt, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007; 13: 95-9.
9. Bulte J, Brooks R. Magnetic nanoparticles as contrast agents for MR imaging. In: Bulte J, Brooks R, ed. Scientific and clinical applications of magnetic carriers New York: Plenum Press; 1997: 527-43.
10. Bulte JWM, Brooks RA, Moskowitz BM, Bryant LH, Frank JA. Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn Reson Med. 1999; 42: 379-84.
11. Shubayev V, Pisanic TR, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Delivery Rev. 2009; 61: 467-77.
12. Laurent S, Bridot JL, Elst LV, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Future Med Chem. 2010; 2: 427-49.
13. Jun YW, Lee JH, Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed. 2008; 47: 5122-35.
14. Na HB, Song IC, Hyeon T. Inorganic Nanoparticles for MRI Contrast Agents. Adv Mater. 2009; 21: 2133-48.
15. Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Delivery Rev. 2010; 62: 284-304.
16. Girard OM, Du J, Agemy L, Sugahara KN, Kotamraju VR, Ruoslahti E, Bydder GM, Mattrey RF. Optimization of Iron Oxide Nanoparticle Detection Using Ultrashort Echo Time Pulse Sequences: Comparison of T1, T2*, and Synergistic T1-T2* Contrast Mechanisms. Magn Reson Med. 2011; 65: 1649-60.
17. Sosnovik DE, Nahrendorf M, Weissleder R. Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol. 2008; 103: 122-30.
18. Khemtong C, Kessinger CW, Ren J, Bey EA, Yang SG, Guthi JS, Boothman DA, Sherry AD, Gao J. In vivo Off-Resonance Saturation Magnetic Resonance Imaging of alpha(v)beta(3)-Targeted Superparamagnetic Nanoparticles. Cancer Res. 2009; 69: 1651-8.
19. Zhang L, Zhong X, Wang L, Chen H, Wang YA, Yeh J, Yang L, Mao H. T1-Weighted Ultrashort Echo Time Method for Positive Contrast Imaging of Magnetic Nanoparticles and Cancer Cells Bound With the Targeted Nanoparticles. J Magn Reson Imaging. 2011; 33: 194-202.
20. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The Effects of Iron-oxides on Porton Relaxivity. Magn Reson Imaging. 1988; 6: 647-53.
21. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT. Superparamagnetic Iron Oxide: Clinical Application as a Contrast Agent for MR Imaging of the Liver. Radiology. 1988; 168: 297-301.
22. Bulte JWM, Zhang SC, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA. 1999; 96: 15256-61.
23. Bulte JWM, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001; 19: 1141-7.
24. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JWM. Clinically applicable labeling of mammalian and stem cells by combining; Superparamagnetic iron oxides and transfection agents. Radiology. 2003; 228: 480-7.
25. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-99.
26. de Vries IJM, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJG, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JWM, Scheenen TWJ, Punt CJA, Heerschap A, Figdor CG. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005; 23: 1407-13.
27. Yang L, Peng X-H, Wang YA, Wang X, Cao Z, Ni C, Karna P, Zhang X, Wood WC, Gao X, Nie S, Mao H. Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer. Clin Cancer Res. 2009; 15: 4722-32.
28. Yang L, Mao H, Wang YA, Cao Z, Peng X, Wang X, Duan H, Ni C, Yuan Q, Adams G, Smith MQ, Wood WC, Gao X, Nie S. Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and Imaging. Small. 2009; 5: 235-43.
29. Qiao J, Li S, Wei L, Jiang J, Long R, Mao H, Wei L, Wang L, Yang H, Grossniklaus HE, Liu Z-R, Yang JJ. HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent. Plos One. 2011;: 6.
30. Yu MK, Park J, Jon S. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy. Theranostics. 2012; 2: 3-44.
31. Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials. 2010; 31: 3016-22.
32. Huang J, Xie J, Chen K, Bu L, Lee S, Cheng Z, Li X, Chen X. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chem Comm. 2010; 46: 6684-6.
33. Louie AY. Multimodality Imaging Probes: Design and Challenges. Chem Rev. 2010; 110: 3146-95.
34. Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Controlled Release. 2011; 149: 314-22.
35. Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H. EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma. Cancer Res. 2010; 70: 6303-12.
36. Koenig SH, Kellar KE. Theory of 1/T1 and 1/T2 NMRD Profiles of Solutions of Magnetic Nanoparticles. Magn Reson Med. 1995; 34: 227-33.
37. Jang JT, Nah H, Lee JH, Moon SH, Kim MG, Cheon J. Critical Enhancements of MRI Contrast and Hyperthermic Effects by Dopant-Controlled Magnetic Nanoparticles. Angew Chem Int Ed. 2009; 48: 1234-8.
38. Seo WS, Lee JH, Sun X, Suzuki Y, Mann D, Liu Z, Terashima M, Yang PC, McConnell MV, Nishimura DG, Dai H. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat Mater. 2006; 5: 971-6.
39. Hacliipanayis CG, Bonder MJ, Balakrishanan S, Wang X, Mao H, Hadjipanayis GC. Metallic Iron Nanoparticles for MRI Contrast Enhancement and Local Hyperthermia. Small. 2008; 4: 1925-9.
40. Hao R, Xing R, Xu Z, Hou Y, Gao S, Sun S. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Adv Mater. 2010; 22: 2729-42.
41. Brooks RA, Moiny F, Gillis P. On T2-shortening by weakly magnetized particles: The chemical exchange model. Magn Reson Med. 2001; 45: 1014-20.
42. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med. 1994; 32: 749-63.
43. Jun YW, Seo JW, Cheon A. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc Chem Res. 2008; 41: 179-89.
44. Jun YW, Huh YM, Choi JS, Lee JH, Song HT, Kim S, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc. 2005; 127: 5732-3.
45. Duan H, Kuang M, Wang X, Wang YA, Mao H, Nie S. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: New insights into spin disorder and proton relaxivity. J Phys Chem C. 2008; 112: 8127-31.
46. Tromsdorf UI, Bigall NC, Kaul MG, Bruns OT, Nikolic MS, Mollwitz B, Sperling RA, Reimer R, Hohenberg H, Parak WJ, Forster S, Beisiegel U, Adam G, Weller H. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett. 2007; 7: 2422-7.
47. Roch A, Gossuin Y, Muller RN, Gillis P. Superparamagnetic colloid suspensions: Water magnetic relaxation and clustering. J Magn Magn Mater. 2005; 293: 532-9.
48. Ai H, Flask C, Weinberg B, Shuai X, Pagel MD, Farrell D, Duerk J, Gao JM. Magnetite-loaded polymeric micelles as ultrasensitive magnetic resonance probes. Adv Mater. 2005; 17: 1949-52.
49. Berret JF, Schonbeck N, Gazeau F, El Kharrat D, Sandre O, Vacher A, Airiau M. Controlled clustering of superparamagnetic nanoparticles using block copolymers: Design of new contrast agents for magnetic resonance imaging. J Am Chem Soc. 2006; 128: 1755-61.
50. Chen H, Yeh J, Wang L, Khurshid H, Peng N, Wang AY, Mao H. Preparation and control of the formation of single core and clustered nanoparticles for biomedical applications using a versatile amphiphilic diblock copolymer. Nano Res. 2010; 3: 852-62.
51. Na HB, Lee JH, An K, Park YI, Park M, Lee IS, Nam DH, Kim ST, Kim SH, Kim SW, Lim KH, Kim KS, Kim SO, Hyeon T. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed. 2007; 46: 5397-401.
52. Shin J, Anisur RM, Ko MK, Im GH, Lee JH, Lee IS. Hollow Manganese Oxide Nanoparticles as Multifunctional Agents for Magnetic Resonance Imaging and Drug Delivery. Angew Chem Int Ed. 2009; 48: 321-4.
53. Tong S, Hou S, Zheng Z, Zhou J, Bao G. Coating Optimization of Superparamagnetic Iron Oxide Nanoparticles for High T(2) Relaxivity. Nano Lett. 2010; 10: 4607-13.
54. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005; 40: 715-24.
55. Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent implications for rational therapy of restenosis. Circulation. 2002; 106: 2842-7.
56. Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, Doan B-T, Gillet B, Combadiere C, Combadiere B, Clement O. In vivo cellular imaging of lymphocyte tracking by MRI: A tumor model approach to cell-based anticancer therapy. Magn Reson Med. 2006; 56: 498-508.
57. Varallyay CG, Muldoon LL, Gahramanov S, Wu YJ, Goodman JA, Li X, Pike MM, Neuwelt EA. Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model. J Cereb Blood F Met. 2009; 29: 853-60.
58. Bulte JWM, Brooks RA. Magnetic nanoparticles as contrast agents for MR imaging-An overview. In: Bulte JWM, Brooks RA, ed. Scientific and Clinical Applications of Magnetic Carriers, 1st ed. New York: Springer; 1997: 527-43.
59. Bulte JWM, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood F Met. 2002; 22: 899-907.
60. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JWM. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003; 107: 2290-3.
61. Bulte JWM, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Method Enzymol. 2004; 386: 275-99.
62. Simon GH, Bauer J, Saborovski O, Fu YJ, Corot C, Wendland MF, Daldrup-Link HE. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol. 2006; 16: 738-45.
63. Korosoglou G, Weiss RG, Kedziorek DA, Walczak P, Gilson WD, Schaer M, Sosnovik DE, Kraitchman DL, Boston RC, Bulte JWM, Weissleder R, Stuber M. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol. 2008; 52: 483-91.
64. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: Cellular MRI using micron-sized iron oxide particles. Magn Reson Med. 2005; 53: 329-38.
65. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. POsitive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med. 2005; 53: 999-1005.
66. Balchandani P, Yamada M, Pauly J, Yang P, Spielman D. Self-Refocused Spatial-Spectral Pulse for Positive Contrast Imaging of Cells Labeled with SPIO Nanoparticles. Magn Reson Med. 2009; 62: 183-92.
67. Stuber M, Gilson WD, Schaer M, Kedziorek DA, Hofmann LV, Shah S, Vonken EJ, Bulte JWM, Kraitchman DL. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-Resonant water suppression (IRON). Magn Reson Med. 2007; 58: 1072-7.
68. Dharmakumar R, Koktzoglou I, Li D. Generating positive contrast from off-resonant spins with steady-state free precession magnetic resonance imaging: theory and proof-of-principle experiments. Phys Med Biol. 2006; 51: 4201-15.
69. Zhang Z, Dharmakumar R, Mascheri N, Fan Z, Wu S, Li D. Comparison of Superparamagnetic and Ultrasmall Superparamagnetic Iron Oxide Cell Labeling for Tracking Green Fluorescent Protein Gene Marker with Negative and Positive Contrast Magnetic Resonance Imaging. Mol Imaging. 2009; 8: 148-55.
70. Zurkiya O, Hu X. Off-resonance saturation as a means of generating contrast with superparamagnetic nanoparticles. Magn Reson Med. 2006; 56: 726-32.
71. Zhou R, Idiyatullin D, Moeller S, Corum C, Zhang H, Qiao H, Zhong J, Garwood M. SWIFT Detection of SPIO-Labeled Stem Cells Grafted in the Myocardium. Magn Reson Med. 2010; 63: 1154-61.
72. Small WC, Nelson RC, Bernardino ME. Dual Contrast Enhancement of Both T1-weighted and T2-weighted Sequences Using Ultrasmall Superparamagnetic Iron-oxide. Magn Reson Imaging. 1993; 11: 645-54.
73. Canet E, Revel D, Forrat R, Baldyporcher C, Delorgeril M, Sebbag L, Vallee JP, Didier D, Amiel M. Superparamagnetic Iron-oxide Particles and Positive Enhancement for Myocardial Perfusion Studies Assessed by Subsecond T1-weighted MRI. Magn Reson Imaging. 1993; 11: 1139-45.
74. Robson MD, Bydder GM. Clinical ultrashort echo time imaging of bone and other connective tissues. NMR Biomed. 2006; 19: 765-80.
75. Hogemann D, Ntziachristos V, Josephson L, Weissleder R. High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjugate Chem. 2002; 13: 116-21.
76. Liu J, Cheng ECH, Long RC, Jr., Yang S-H, Wang L, Cheng P-H, Yang J, Wu D, Mao H, Chan AWS. Noninvasive Monitoring of Embryonic Stem Cells In Vivo with MRI Transgene Reporter. Tissue Eng. 2009; 15: 739-47.
77. Liu W, Dahnke H, Rahmer J, Jordan EK, Frank JA. Ultrashort T2* Relaxometry for Quantitation of Highly Concentrated Superparamagnetic Iron Oxide (SPIO) Nanoparticle Labeled Cells. Magn Reson Med. 2009; 61: 761-6.
78. Khemtong C, Togao O, Ren J, Kessinger CW, Takahashi M, Sherry AD, Gao J. Off-resonance saturation MRI of superparamagnetic nanoprobes: Theoretical models and experimental validations. J Magn Reson. 2011; 209: 53-60.
79. Langley J, Liu W, Jordan EK, Frank JA, Zhao Q. Quantification of SPIO Nanoparticles in vivo Using the Finite Perturber Method. Magn Reson Med. 2011; 65: 1461-9.
80. Zhao Q, Langley J, Lee S, Liu W. Positive contrast technique for the detection and quantification of superparamagnetic iron oxide nanoparticles in MRI. NMR Biomed. 2011; 24: 464-72.